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Obesity and hypertension are strongly associated, and neural dysfunction has been implicated in both. The
hypothalamus integrates signals regulating blood pressure and energy homeostasis. A recent paper in
Nature Medicine (Purkayastha et al., 2011) suggests that obesity and hypertension are caused by inflamma-
tion in distinct hypothalamic neuronal populations.The rising prevalence of obesity is
a serious public health problem, particu-
larly in the U.S. Excess fat mass is
associated with increased cardiovascular
morbidity and mortality in part because it
induces hypertension (Esler et al., 2006).
Moreover, obesity is a major risk factor
for resistant hypertension, defined as
patients who have uncontrolled blood
pressure despite use of three or more
antihypertensive medications (Persell,
2011). Although the mechanisms involved
in the pathogenesis of obesity-associated
hypertension are not completely under-
stood, it is increasingly clear that central
neural mechanisms via activation of the
sympathetic nervous system play a pivo-
tal role (Rahmouni et al., 2005; Esler
et al., 2006). There is also increasing
epidemiological, clinical, and experi-
mental evidence that inflammation is
causally linked to both obesity (Gregor
and Hotamisligil, 2011) and hypertension
(Zubcevic et al., 2011), and the transcrip-
tion factor nuclear factor kappa B (NF-kB)
and its upstream regulator kappa B
kinase beta (IKKb) have emerged as key
players (Figure 1). The fundamental
importance of the IKKb/NF-kB axis in the
pathogenesis of obesity is well docu-
mented, particularly in peripheral tissues
(Gregor and Hotamisligil, 2011; Lumeng
and Saltiel, 2011). Recently, activation of
the IKKb/NF-kB axis in a subpopulation
of hypothalamic neurons has been shown
to play a key role in energy homeostasis
and obesity (Zhang et al., 2008).
The importance of the central nervous
system, particularly the hypothalamus, inblood pressure regulation, along with
the established links between obesity
and hypertension, raises the question
of whether hypothalamic IKKb/NF-kB
signaling is involved in blood pressure
regulation. Cai and colleagues (Purkayas-
tha et al., 2011) address this question
using a series of elegant gain- and loss-
of-function experiments. Their data
suggest that activity of IKKb/NF-kB in
hypothalamic neurons does indeed regu-
late arterial pressure. Virally or pharmaco-
logically mediated upregulation of IKKb/
NF-kB activity in the mediobasal hypo-
thalamus causes a significant elevation
in arterial pressure in mice. Conversely,
blockade of mediobasal hypothalamic
IKKb/NF-kB activity with a virus express-
ing a dominant-negative mutant of IKBa
prevents the hypertension caused by
diet-induced obesity, a condition associ-
ated with upregulation of hypothalamic
NF-kB activity (Zhang et al., 2008). This
viral treatment has no effect on basal arte-
rial pressure in lean mice.
One of the most intriguing observations
of the study is that the effects on arterial
pressure resulting from modulating hypo-
thalamic IKKb/NF-kB activity appear
unrelated to changes in body weight and
adiposity, suggesting a dissociation
between the hypothalamic mechanisms
controlling energy homeostasis and arte-
rial pressure in obesity. In the authors’
previous study, alterations in hypotha-
lamic IKKb/NF-kB signaling caused
dramatic changes in bodyweight in obese
mice (Zhang et al., 2008). Importantly,
those studies were performed overCell Metaboa period of several weeks. In contrast,
the protocols employed in the Nature
Medicine study were short-term, thus
resulting in insignificant changes in food
intake and body weight. This provided
the opportunity to examine effects on
cardiovascular endpoints without con-
founding changes in body weight. The
activity of the sympathetic nervous
system was identified as a key mediator
of the effect of hypothalamic IKKb/NF-
kB signaling on arterial pressure. This is
based on several observations, includ-
ing spectral analysis of radiotelemetry
recordings of arterial pressure and heart
rate, changes in plasma catecholamine
levels, and the efficacy of pharmacolog-
ical blockade of a-adrenergic receptors
to prevent the arterial pressure elevation
induced by upregulation of hypothalamic
IKKb/NF-kB activity. These findings are
in line with the emerging role of the
mediobasal hypothalamus in sympathetic
nerve regulation (Harlan et al., 2011).
Furthermore, these findings are consis-
tent with the well-established importance
of neurogenic mechanisms in the patho-
physiology of obesity-associated hyper-
tension (Esler et al., 2006).
The investigators next delineated the
specificneuronalpopulationwithin theme-
diobasal hypothalamus responsible for
modulating the arterial pressure effect of
IKKb/NF-kB. In so doing, they focused on
two neuronal populations located in the
arcuate nucleus that receive and integrate
signals from the periphery, including leptin
and insulin, i.e., neurons expressing pro-
opiomelanocortin (POMC) and neuronslism 14, July 6, 2011 ª2011 Elsevier Inc. 3
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Figure 1. Differential Involvement of IKKb/NF-kB Signaling in Neurons of the Hypothalamic
Arcuate Nucleus in the Pathogenesis of Obesity and Hypertension
There are two key neuronal populations in the arcuate nucleus: the pro-opiomelanocortin (POMC) neurons
and the neuropeptide Y (NPY) neurons, which also express agouti-related protein (AgRP). IKKb/NF-kB
axis in the orexigenic NPY/AgRP neurons is required for the development of diet-induced obesity. On
the other hand, IKKb/NF-kB axis in the POMC neurons mediates the obesity-associated hypertension
via activation of the sympathetic nervous system (SNS). The inset shows the pathway for IKKb/NF-kB
signaling that leads to the modulation of gene expression. Under basal conditions, inactive NF-kB resides
in the cytoplasm bound to the inhibitory protein IKBa. Phosphorylation of IKBa causes it to be released
from NF-kB, ubiquitinated, and degraded in the proteasome. The phosphorylation of IKBa is facilitated
by the IkB kinase IKKb, which is itself activated via serine phosphorylation in response to activation of
cell surface receptors such as IL-1b, TNFa, or the toll-like receptors or in response to reactive oxygen
species. Free of IKB, NF-kB can then translocate to the nucleus, where it modulates the transcription of
its target genes.
Cell Metabolism
Previewsexpressing neuropeptide Y/agouti-related
protein (NPY/AgRP) (Figure 1). They first
examined the arterial pressure response
toacute inflammation causedby intracere-
broventricular injection of TNF-a and then
assessed the response to high-fat diet.
Interestingly, Cre-LoxP-mediated ablation
of IKKb in POMC neurons, but not NPY/
AgRP neurons, resulted in a blunting of
thepressoreffectscausedbyacuteactiva-
tion of the IKKb/NF-kB axis by TNF-a.
Moreover, while ablation of IKKb from
POMC neurons did not alter basal arterial
pressure levels in lean mice, it was suffi-
cient to prevent the development of hyper-
tension caused by high-fat feeding. These
results suggest that activation of the NF-
kB pathway in POMCneurons in response
to inflammatory stimuli is required to raise4 Cell Metabolism 14, July 6, 2011 ª2011 Elsarterial pressure. The data also imply that
activation of the inflammatory pathway in
POMC neurons may mediate the arterial
pressure elevation in obesity (Figure 1).
The contribution of IKKb in NPY/AgRP
neurons in obesity-associated hyperten-
sion is a question that remains un-
answered and deserves further investi-
gation. The authors provide indirect
evidence that this signaling pathway in
NPY/AgRP neurons may not be required
for the blood pressure elevation that
accompanies obesity. This is based on
their finding that selective ablation of
IKKb from POMC neurons completely
reversed obesity-induced hypertension
despite the preservation of IKKb in
NPY/AgRP neurons. Obtaining direct
evidence for the contribution of IKKb/evier Inc.NF-kB signaling in NPY/AgRP neurons
to obesity-associated hypertension is
challenging because mice bearing a tar-
geted deletion of IKKb from NPY/AgRP
neurons are resistant to obesity induced
by high-fat diet (Zhang et al., 2008).
The study by Cai and colleagues high-
lights the importance of arcuate nucleus
IKKb/NF-kB signaling in arterial pressure
regulation and in obesity-associated
hypertension. Important next steps will
include determining the upstream signals
driving activity of the hypothalamic IKKb/
NF-kB axis, the involvement of NF-kB
target genes and pathways, and the
neural circuits through which they act.
For instance, how do other hypothalamic
and extra-hypothalamic cardioregulatory
nuclei interface with IKKb/NF-kB
pathways in POMC neurons in obesity-
associated hypertension? This is critical
because POMC neurons form complex
circuits with other energy homeostasis
and cardioregulatory centers of the brain
(Ghamari-Langroudi et al., 2011). Finally,
it will be important to determine whether
the involvement of the IKKb/NF-kB axis
in POMC neurons is limited to obesity-
associated hypertension or applies to
other forms of hypertension.REFERENCES
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